AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 13 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $7,206,000 | -3.5% | 7,424,000 | 0.0% | 3.24% | +9.2% |
| Q3 2018 | $7,467,000 | -3.7% | 7,424,000 | 0.0% | 2.97% | -20.7% |
| Q2 2018 | $7,757,000 | -1.8% | 7,424,000 | 0.0% | 3.74% | -9.6% |
| Q1 2018 | $7,901,000 | +6.4% | 7,424,000 | 0.0% | 4.14% | -8.9% |
| Q4 2017 | $7,424,000 | -5.9% | 7,424,000 | 0.0% | 4.54% | -7.2% |
| Q3 2017 | $7,888,000 | +1.8% | 7,424,000 | 0.0% | 4.89% | +4.8% |
| Q2 2017 | $7,748,000 | -45.2% | 7,424,000 | -25.8% | 4.66% | -62.4% |
| Q4 2016 | $14,144,000 | -27.8% | 10,000,000 | -42.0% | 12.41% | -32.5% |
| Q3 2016 | $19,597,000 | +2.4% | 17,250,000 | 0.0% | 18.38% | +82.5% |
| Q2 2016 | $19,146,000 | – | 17,250,000 | – | 10.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 17,250,000 | $19,597,000 | 18.38% |
| STEELHEAD PARTNERS LLC | 17,000,000 | $19,264,000 | 1.88% |
| Bruce & Co., Inc. | 5,500,000 | $6,600,000 | 1.78% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 26,750,000 | $30,177,000 | 1.01% |
| Castle Creek Arbitrage, LLC | 3,721,000 | $4,215,000 | 0.43% |
| LINDEN ADVISORS LP | 7,000,000 | $7,909,000 | 0.36% |
| Sonora Investment Management, LLC | 1,510,000 | $1,702,676,000 | 0.36% |
| BASSO CAPITAL MANAGEMENT, L.P. | 2,110,000 | $2,382,000 | 0.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,808,000 | 0.31% |
| SSI INVESTMENT MANAGEMENT LLC | 1,975,000 | $2,221,000 | 0.20% |